US Supply Of OTC COVID-19 Tests Gets Boost Through $231.8M Contract For Australian Firm

02 Feb 2021

Biden administration seems to be betting Elluve's OTC at-home antigen diagnostic test will be a game changer in helping stop the spread of the coronavirus.

The Biden administration has given Ellume $213.8M to build a factory in the US to produce their at-home OTC COVID-19 test. — The Biden administration awards contract for supply of Ellmune's COVID-19 Home Test. • Source: Source: Shutterstock / Ellume Health (Shutterstock)

US Supply Of OTC COVID-19 Tests Gets Boost Through $231.8M Contract For Australian Firm

More from Asia

More from Geography